Johanna Olweus

Image of Johanna Olweus
Norwegian version of this page
Phone +47-22781325
Mobile phone 90054934
Username
Visiting address Ullernchausseen 70 0372 OSLO
Postal address Postboks 4950 Nydalen 0424 OSLO

Head of K.G. Jebsen Centre for Cancer Immunotherapy.

Tags: Cancer, Immunotherapy, Life science

Publications

Bellow is a list of selected publications.

A full list can be found here.

  • Kolstad A, Kumari S, Walczak M, Madsbu U, Hagtvedt T, Bogsrud TV, Kvalheim G, Holte H, Aurlien E, Delabie J, Tierens A, Olweus J. Sequential intranodal immuntherapy induces anti-tumor immunity and correlated regression of disseminated follicular lymphoma. Blood 2014 Oct 7 pii: blood-2014-07-592162. [Epub ahead of print]
  • Kumari S, Walchli S, Fallang LE, Yang W, Lund-Johansen F, Schumacher TN, Olweus J. Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes. Proc Natl Acad Sci U S A. 2014;111(1):403-408. 
    Selected by Faculty of 1000 Prime:http://f1000.com/prime/718206020?bd=1 (Two stars)
  • Lossius A, Johansen JN, Vartdal F, Robins H, Benth JS, Holmoy T, Olweus J. High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8 T cells. Eur J Immunol. 2014.
  • Walchli S, Kumari S, Fallang LE, Sand KM, Yang W, Landsverk OJ, . . . Olweus J*, Gregers TF*. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation. Eur J Immunol. 2014;44(3):774-784. 
    *Shared senior authors. Front cover. Commentary in Eur J Immunol 2014, V44, p650. 
    Selected by Faculty of 1000 Prime: http://f1000.com/prime/718194774?bd=1&ui=28053
  • Taraldsrud E, Fevang B, Aukrust P, Beiske KH, Floisand Y, Froland S, . . . Olweus J. Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9. Clin Exp Immunol. 2014;175(3):439-448.
  • Abrahamsen IW, Kjellevoll S, Greve-Isdahl M, Mensali N, Walchli S, Kumari S, . . . Olweus J. T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells. Int J Cancer. 2012;130(8):1821-1832.
  • Abrahamsen IW, Stronen E, Walchli S, Johansen JN, Kjellevoll S, Kumari S, . . . Olweus J. Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif. Leukemia. 2010;24(11):1901-1909.
Published Apr. 13, 2011 2:55 PM - Last modified May 27, 2016 11:44 AM